Hint mode is switched on Switch off
For swift navigation between sections

Societal CDMO
LEI 2549004EL1Z016VYWA54

PDF download

Choose all Reset all
Download Cancel
Organization name
Societal CDMO Inc (formerly Recro Pharma, Inc.)
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Societal CDMO Inc is a specialty pharmaceutical company. The Company develops non-opioid therapeutics for the treatment of pain in the post-operative setting. Societal CDMO offers its products to the medical industry.

Awards

News

08/04/2024 Societal CDMO: Of This Current Report On Form, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Material Modification To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
14/03/2024 Societal CDMO: Other Events
28/02/2024 Societal CDMO: Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits
21/11/2023 Societal CDMO: Entry Into A Material Definitive Agreement, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Financial Statements And Exhibits
24/08/2023 Societal CDMO: Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show more Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    2549004EL1Z016VYWA54
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001588972
  • EIN
    26-1523233
Registration is required to get access.